사이클린 의존성 인산화효소의 발현 또는 활성 억제제의 존부를 조절하여 성체 줄기세포와 신경세포 간의 분화를 유도하는 방법
    11.
    发明公开
    사이클린 의존성 인산화효소의 발현 또는 활성 억제제의 존부를 조절하여 성체 줄기세포와 신경세포 간의 분화를 유도하는 방법 有权
    通过控制细胞周期依赖性激酶的表达或活性将诱导成骨细胞分化为神经细胞的方法

    公开(公告)号:KR1020120008239A

    公开(公告)日:2012-01-30

    申请号:KR1020100068981

    申请日:2010-07-16

    Abstract: PURPOSE: A method for differentiation and dedifferentiation between adult stem cells and neural cells is provided to enhance differentiation efficiency and to be applied in various therapeutic methods for treating nervous diseases. CONSTITUTION: A method for inducing differentiation between adult stem cells and neural cells comprises a step of controlling an inhibitor of expression or activation of CDKs(cyclin-dependent kinase). The adult stem cells are differentiated into neural cells by treating the inhibitor. The neural cells are dedifferentiated from neural cells into adult stem cells by removing the inhibitor. The inhibitor includes a compound, siRNA, shRNA, antisense olibonucleotide, or antibody. The shRNA for CDK1, CDK2, and CDK4 contains a base sequence of sequence numbers 13 or 14, 15 or 16, and 17 or 18, respectively.

    Abstract translation: 目的:提供成体干细胞和神经细胞分化和去分化的方法,以提高分化效率,并应用于治疗神经疾病的各种治疗方法。 构成:诱导成体干细胞与神经细胞分化的方法包括控制CDK(细胞周期蛋白依赖性激酶)的表达或活化抑制剂的步骤。 通过治疗抑制剂将成体干细胞分化成神经细胞。 通过去除抑制剂,将神经细胞从神经细胞去分化成成体干细胞。 抑制剂包括化合物,siRNA,shRNA,反义寡核苷酸或抗体。 CDK1,CDK2和CDK4的shRNA含有序列号分别为13或14,15或16和17或18的碱基序列。

Patent Agency Ranking